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Background: Moringa stenopetala has been used in traditional health systems to treat diabetes mellitus. One of the
successful methods to prevent of the onset of diabetes is to control postprandial hyperglycemia by the inhibition
of α-glucosidase and pancreatic α-amylase activities, resulting in the aggressive delay of the carbohydrate digestion
of absorbable monosaccharides. The aim of the present study is to investigate the effect of the extract of the leaves
of Moringa stenopetala on α-glucosidase, pancreatic α-amylase, pancreatic lipase, and pancreatic cholesterol esterase
activities, and, therefore find out the relevance of the plant in controlling blood sugar and lipid levels.
Methods: The dried leaves of Moringa stenopetala were extracted with hydroalcoholic solvent and dried using rotary
vapor under reduced pressure. The dried extracts were determined for the total phenolic compounds, flavonoid content
and condensed tannins content by using Folin-Ciocateu’s reagent, AlCl3 and vanillin assay, respectively. The dried extract
of plant-based food was further quantified with respect to intestinal α-glucosidase (maltase and sucrase) inhibition and
pancreatic α-amylase inhibition by glucose oxidase method and dinitrosalicylic (DNS) reagent, respectively.
Results: The phytochemical analysis indicated that flavonoid, total phenolic, and condensed tannin contents in the
extract were 71.73 ± 2.48 mg quercetin equivalent/g of crude extract, 79.81 ± 2.85 mg of gallic acid equivalent/g of
crude extract, 8.82 ± 0.77 mg catechin equivalent/g of crude extract, respectively. The extract inhibited intestinal sucrase
more than intestinal maltase with IC50 value of 1.47 ± 0.19 mg/ml. It also slightly inhibited pancreatic α-amylase,
pancreatic lipase and pancreatic cholesterol esterase.
Conclusion: The result demonstrated the beneficial biochemical effects of Moringa stenopetala by inhibiting intestinal
α-glucosidase, pancreatic cholesterol esterase and pancreatic lipase activities. A daily supplement intake of the leaves of
Moringa stenopetala may help in reducing hyperglycemia and hyperlipidemia.
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Worldwide, the number of people with diabetes and
pre-diabetes is exponentially increasing mainly due to
aging, urbanization, unhealthy eating habits, increasing
prevalence of obesity and lack of physical activity [1].
Diabetes mellitus is a leading cause of morbidity and
mortality worldwide, with an estimated 382 million* Correspondence: alemayehutoma@gmail.com
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unless otherwise stated.adults being affected and 5.1 million people killed in the
year 2013. The prevalence is expected to be 592 million
in the year 2035, with the greatest increases expected in
low- and middle-income developing countries of the
African, Asian, and South American regions. At present,
80% of the worlds’ populations with diabetes live in
low- and middle income countries [2]. Diabetes is also
associated with a host of life threatening and potentially
disabling macro- and micro-vascular complications [3].
Hence, there is a much larger burden in the form of loss
of productivity as a result of restricted daily activity
which results in high economic costs.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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family Moringaceaeis commonly grown in Southern
parts of Ethiopia [4]. The leaves of Moringa stenopetala
are cooked and eaten as vegetables and the leaves
and roots are used to treat malaria, diabetes, asthma,
repelled placenta, hypertension and gastrointestinal
problems [5,6]. It has been reported that Moringa steno-
petala leaves and roots showed antitrypanosomal activity
[7]. The antispasmodic effects of the leaves on smooth
muscle tissues and antibiotic properties of the seeds
[5,8] have also been reported. The crude aqueous extract
of the leaves demonstrated hypoglycemic activity [9].
The crude aqueous/ethanol extract and fractions of
the leaves of Moringa stenopetala have been reported
to have both hypoglycemic and antihyperglycemic
effect [10,11]. Moreover, chronic administration of the
n-butanol fraction of ethanol extract of Moringa steno-
petala leaves in alloxan-induced diabetic mice showed
antihyperglycemic and antihyperlipedimic effects with
wide margins of safety, indicating its potential for long
term management of diabetes [12].
The aim of the present study was to investigate the in-
hibitory effect of the leaf extract of Moringa stenopetala
on α-glucosidase, pancreatic α-amylase, pancreatic lip-




Folin-Ciocalteu, quercetin, catechin, gallic acid, rat intes-
tinal acetone powder, porcine pancreatic α-amylase,
vanillin, 3,5-dinitrosalicylic acid, glucose oxidase kits,
p-nitrophenylbutylrate (p-NPB), p-nitrophenylpalmitate
(p-NPP), taurodeoxycholic acid, taurocholic acid, porcine
cholesterol esterase, porcine pancreatic lipase were pur-
chased from Sigma-Aldrich Co. (St. Louis, MO, USA). All
others chemicals used were of analytical grade.
Collections and preparation of plant materials
The leaves of Moringa stenopetala was collected from
Gamo Gofa Zone, South Nation’s Nationalities Peoples
Region, 520 kilometer south of Addis Ababa. After col-
lection, the plant was identified and authenticated by a
taxonomist, and deposited in herbarium of Ethiopian
nutrition and health research institute (ENHRI) with a
voucher number AL-001. It was then dried under shade
and crushed to powder for extraction.
Preparation of plant material extract
The powdered leaves (1.2 Kg) were extracted by percola-
tion using 70%( v/v) ethanol, and the mixture was
then filtered using Whatmann filter paper no. 1. The ex-
tract was dried by evaporation using rotary vaporizers
under reduced pressure at a temperature of 40-45°C.The residue filtrate obtained was then dried by steam
bath at 40°C and kept in refrigerator at 8°C for experi-
mental usage. The yield of the extract was 20.1% in
weight by weight (w/w).
Determination of flavonoid content
Estimation of flavonoid content in the dried extracts was
done according to a previous method [13]. The dried ex-
tract (0.5 mg) was dissolved in 80% ethanol (1 ml). The
sample solution (50 μl) was added to 10 μl of AlCl3
solution (10% w/v) and 10 μl of 1 M sodium acetate in
absolute ethanol (150 μl). After incubation at 30°C for
30 min, the absorbance was measured immediately at
430 nm. The estimation of flavonoid content was calcu-
lated from a calibration curve using quercetin as a
standard. The results were expressed as milligram quer-
cetin equivalent/gram dry weight of extract.
Flavonoid mg=gð Þ ¼ Abs test sample‐Absblankð Þ‐Intercept
Slope amountof sample in gram
Where Abs test sample was the absorbance of extract
with reagent, Abs blank was the absorbance of extract
without reagent.
Determination of total phenolic content
Total phenolic content of the extract was performed ac-
cording to a previous method [13]. The dried extract
(0.5 mg) was dissolved in distilled water (1 ml). The sample
solution (50 μl) was mixed with 50 μl of Folin-Ciocateu’s
reagent followed by 50 μl of Na2CO3 (10% w/v). After in-
cubation at 30°C for 60 min, the absorbance was measured
at 760 nm using a microplate reader. Total phenolic con-
tent was calculated from a calibration curve using gallic
acid as a standard. The results were expressed as milligram
gallic acid equivalent/gram dry weight of extract.
Total phenolic compounds mg=gð Þ
¼ Abs test sample‐Abs blankð Þ‐Intercept
Slope  amount of sample in gram
Where Abs test sample was the absorbance of extract
with reagent, Abs blank was the absorbance of extract
without reagent.
Determination of condensed tannin content
Estimation of condensed tannin content in the dried ex-
tracts was done according to a previous method [14].
The dried extract (5 mg) was dissolved in 80% ethanol
(1 ml). The sample solution (50 μl) was added to 100 μl
of vanillic acid solution (4% w/v) and 50 μl of concen-
trated HCl. The absorbance was measured immediately
at 500 nm. The estimation of condensed tannin content
was calculated from a calibration curve using catechin
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catechin equivalent/gram dry weight of extract.
Condensed tannins mg=gð Þ ¼ Abs test sample‐Abs blankð Þ‐Intercept
Slope amount of sample in gram
Where Abs test sample was the absorbance of extract
with reagent, Abs blank was the absorbance of extract
without reagent.
Pancreatic α-amylase inhibitory activity
The pancreatic α-amylase inhibition assay was per-
formed according to a previous report [15]. Porcine pan-
creatic α-amylase (3units/ml) was dissolved in 0.1 M
phosphate buffer saline, pH 6.9. The various concentra-
tions of the extract (10 μl) were added to a solution con-
taining starch (1 g/l) and phosphate buffer (165 μl). The
reaction was initiated by adding enzyme solution (75 μl)
to the incubation medium. After 10 min incubation, the
reaction was stopped by adding 250 ml dinitrosalicylic
(DNS) reagent (1% 3, 5-dinitrosalicylic acid, 0.2% phenol,
0.05% Na2SO3 and 1% NaOH in aqueous solution) to
the reaction mixture. The mixtures were heated at 100°C
for 10 min in order to stop the reaction. Thereafter,
250 μl of 40% potassium sodium tartarate solution was
added to the mixtures to stabilize the color. After cool-
ing to room temperature in a cold water bath, the ab-
sorbance was recorded at 540 nm using a microplate
reader. Acrabose was used as positive control.
%Inhibition ¼ AbsContol‐AbsSample 100
AbsControl
Where Abs Control was the absorbance without sam-
ple, Abs samples was the absorbance of sample extract.
Intestinal α-glucosidase inhibitory activity
The assessment of intestinal α-glucosidase inhibitory ac-
tivity was based on the modified method previously de-
scribed [15]. Briefly, 100 mg of rat intestinal acetone
powder was homogenized in 3 ml of 0.9% NaCl solution.
The solution was centrifuged at 12,000 g for 30 min
and then subjected to assay. The crude enzyme solution
(as maltase assay, 10 μl; as sucrase assay, 30 μl) was in-
cubated with 30 μl maltose (86 mM) or 40 μl sucrose
(400 mM), 10 μl of the extract at various concentrations,
followed by the addition of 0.1 M phosphate buffer,
pH 6.9 to give a final volume of 100 μl. The reaction
was incubated at 37°C for 30 min (maltase assay) or
60 min (Sucrase assay). Thereafter, the mixtures were
suspended in boiling water for 10 min to stop the reac-
tion. The concentrations of glucose released from the
reaction mixtures was determined by glucose oxidase
method with absorbance at a wavelength of 450 nm.
Intestinalα-glucosidase inhibitory activity was expressedas percentage inhibition using the following formula.




Where Abs Control was the absorbance without sam-
ple, Abs samples was the absorbance of sample extract.
Pancreatic cholesterol esterase inhibition
The pancreatic cholesterol esterase inhibition was per-
formed spectrophotometrically based on previous method
[13]. The extract was incubated with mixtures containing
5.16 mM taurocholic acid, 0.2 mM p-NPB in 100 mM so-
dium phosphate buffer, 100 mM NaCl, pH 7.0. The reac-
tion was initiated by adding porcine pancreatic cholesterol
esterase (1 μg/ml). After incubation for 5 min at 25°C, the
mixtures were measured the absorbance at 405 nm. Sim-




Where Abs Control was the absorbance without sam-
ple, Abs samples was the absorbance of sample extract.
Pancreatic lipase inhibition
The pancreatic lipase inhibition was performed spectro-
photometrically based on previous method with little
modification [16]. The extract was incubated with mix-
tures containing 5 mM deoxytaurocholic acid, 0.2 mM
p-NPP in 50 mM sodium phosphate monobasic buffer,
pH 8.0. The reaction was initiated by adding porcine
pancreatic lipase (10 mg/ml). After incubation for 5 min
at 37°C, the mixtures were measured the absorbance at




Where Abs Control was the absorbance without sam-
ple, Abs samples was the absorbance of sample extract.
Data analysis
The IC50 values were calculated from plots of log concen-
tration of inhibitor concentration versus percentage inhib-
ition curves using sigma plot version11. The data were
expressed as mean ± standard error of mean (SEM).
Results
The amount of total flavonoids, total polyphenolic com-
pounds, and condensed tannins contents determined in
the extract are summarized in Table 1. The content of
flavonoid in the extract was 71.73 ± 2.48 mg quercetin
equivalent/g of crude extract. The total polyphenolic
compound in the extract was 79.81 ± 2.85 mg of gallic
Table 1 Flavonoid, total phenolic, and condensed tannin contents of Moringa stenopetala leaves extract
Phytochemical analysis
Flavonoid (mg/g extract) Total phenolics (mg/g extract) Condensed tannins (mg/g extract)
Moringa stenopetala 71.73 ± 2.48 79.81 ± 2.85 8.82 ± 0.77
Results are expressed as means ± S.E.M., n = 3.
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tent of condensed tannins in the extract was found to be
8.82 ± 0.77 mg catechin equivalent/g of crude extract.
As shown in Table 2, the IC50 value of the extract was
1.47 ± 0.19 mg/ml for intestinal sucrase, where as the
extract (5 mg/ml) inhibited intestinal maltase by 48.64 ±
1.18%. The findings indicated that the extract was a
more specific inhibitor of intestinal sucrase than intes-
tinal maltase. The extract also inhibited pancreatic
cholesterol esterase activity (49.22 ± 2.34) more than
pancreatic α-amylase (6.06 ± 0.75%). Moreover, it was
found that the extract inhibited pancreatic lipase with
IC50 value of greater than 5 mg/ml.
Discussion
Diabetes mellitus is a metabolic disorder that usually af-
fects carbohydrate, fat, and protein metabolism, followed
by multiorgan injury in the later period, and hyperipide-
mia is associated with hyperglycemia [17]. More power-
ful new compounds with pan-target activity and proven
long-term safety should be highly effective in a clinical
setting for patients with coexisting relevant lipid and
glucose metabolic disorders. These discoveries pave the
way for the development of drugs for treating chronic
multigenic metabolic and cardiovascular diseases, for
which therapy is presently insufficient or nonexistent
[18]. This is the first study to investigate the effect of leaf
extract of Moringa stenopetala on pancreatic and intes-
tinal enzymes related to antihyperglycemic and antihy-
perlipidemic actvities.
The presence of phytochemicals in plant products gives
a great potential for balancing metabolic disturbances.
Several phytomolecules including flavonoids, phenolic
compounds, alkaloids, glycosides, saponins, glycolipids,
dietary fibres, polysaccharides, peptidoglycans, carbohy-
drates, amino acids and others obtained from various
plant sources have been reported as potent hypoglycemic
agents. Flavonoids are a heterogeneous group of ubiqui-
tous plant polyphenols, which exhibit a variety of pharma-
cological activities, including the anti-atherogenic as well
as antihyperglycemic effects, lipoprotein oxidation, bloodTable 2 The inhibitory effects of Moringa stenopetala leaf ext
lipase, and pancreatic cholesterol esterase activities
IC50 values
Pancreatic α-Amylase Maltase Su
Moringa stenopetala > 5 > 5 1.4
Results are expressed as means ± S.E.M., n = 3.platelet aggregation and vascular reactivity [19]. A high
content of phytochemicals especially total polyphenolic
compounds and total flavonoids may contribute to the
pleiotropic effects of Moringa stenopetala leaves that sup-
port the use of the plant for different metabolic disorders
in the local community.
It is well known that inhibition of intestinal α-glucosidase
and pancreatic α-amylase activity results in delaying carbo-
hydrate digestion of absorbable monosaccharides, causing
reduction of postprandial hyperglycemia. The plant extract
showed a weaker pancreatic α-amylase activity compared
to intestinal α-glucosidase activity. α-glucosidase inhibitors
delay intestinal carbohydrate absorption and slow the sharp
rise in blood sugar levels that diabetic patients typically ex-
perience after snacks. However, none of the currently avail-
able α-glucosidase inhibitors for clinical use are devoid of
severe adverse effects [20,21]. The search for new group of
agents from natural resources especially from traditional
medicines has, therefore, become an attractive approach for
the treatment of postprandial hyperglycemia. Our study
showed that hydroalcoholic leaf extract of Moringa steno-
petala is a potent inhibitor of α-glucosidase activity, and
therefore suggests that extracts of Moringa stenopetala
could be an attractive source of alternative treatment.
Besides hyperglycemia, diabetes mellitus is highly
characterized by elevated levels of triglycerides and chol-
esterol in the blood highly associated with a modern life-
style and increase consumption of a high fat diet [22].
Reducing absorption of free fatty acids and free choles-
terol by inhibiting pancreatic lipase and pancreatic chol-
esterol esterase reduces hyperlipidemia associated with
diabetes mellitus [23,24]. In our previous findings it was
reported that the plant material of Moringa stenopetala
has antihyperlipidemic effects [12] which may be due to
the inhibition of pancreatic lipase and pancreatic choles-
terol esterase.
Conclusion
In conclusion, we demonstrate here that the inhibition of
intestinal α-glucosidase by extracts of Moringa stenopetala
may contribute to antihyperglycemic activity. Extracts ofract on pancreatic α-amylase, maltase, sucrase, pancreatic
(mg/ml)
crase Pancreatic lipase Pancreatic cholesterol esterase
7 ± 0.19 >5 >5
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due to the inhibition of lipase and cholesterol esterase
enzymes. Thus plant material of Moringa stenopetala
could be used for prevention/treatment of hyperglycemia
and hyperlipidemia. Further illustration on mechanism(s)
of Moringa stenopetala leaves on insulin secretion and
plasma lipid inhibition on animal models, and role of the
plant material for management of protein glycation are be-
ing investigated.
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